By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 11th IMPACCT: Real World Evidence Summit 2023, an industry-leading event that delves deep into the world of Real World Evidence (RWE) and its impact on regulatory submissions and clinical trial innovation. This three-day summit brings together over 100 senior leaders in RWE, real-world analytics experts, and epidemiologists from the pharmaceutical and biotech industries.In light of exciting changes from the FDA and EMA, this comprehensive forum provides a platform to discuss how drug developers can effectively utilize RWE throughout the entire lifecycle of a study. By incorporating RWE from the outset, clinical studies can be designed with precision, ensuring patient safety, data integrity, and appropriate protections.With over 18 hours of exclusive content, this summit offers a unique opportunity to learn from your peers and industry experts. One of the key highlights is exploring how to leverage the new FDA external controls draft guidance. Attendees will gain insights into creating synthetic control arms using RWE, electronic health record (EHR) data, and artificial intelligence. This innovative approach opens doors for enhanced clinical trial design and the exploration of new treatment avenues.Moreover, the summit focuses on utilizing RWE to target specific patient populations and drive diversity, equity, and inclusion (DE&I) in clinical trials. By harnessing the power of RWE, drug developers can better understand the real-world impact of their therapies and ensure their efficacy and safety across diverse patient groups.The IMPACCT: Real World Evidence Summit 2023 promises to be a highly engaging and collaborative event, fostering discussions, knowledge sharing, and networking opportunities among industry leaders. Don't miss this chance to gain valuable insights into the evolving landscape of RWE and its transformative potential in disease treatment.
Discover the use of RWE for regulatory submissions and clinical trial innovation.
Learn how to leverage the new FDA external controls draft guidance to create synthetic control arms using RWE, as well as EHR data and artificial intelligence.
Deep dive into the use of RWE for regulatory submissions and clinical trial innovation to unlock unstructured healthcare data and transform disease treatment.
Listen to experts in RWE, RWD, real world analytics experts & epidemiologists from pharma and biotech and get inspired.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice.
OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes.
Verana Health is a digital health company that delivers quality drug lifecycle, medical practice, and medical society insights from an exclusive real-world data network of more than 20,000 healthcare providers.
PointClickCare is the market leader driving the transformation of healthcare vulnerable and complex populations through a broad, connected care network powered by deep insights with a commitment to value, outcomes and innovation.
HealthVerity synchronizes transformational technologies with the nation’s largest healthcare and consumer data ecosystem to power previously unattainable outcomes and fundamentally advance the science. We offer a comprehensive, yet flexible approach,
HealthVerity synchronizes transformational technologies with the nation’s largest healthcare and consumer data ecosystem to power previously unattainable outcomes and fundamentally advance the science. We offer a comprehensive, yet flexible approach, based on the foundational elements of Identity, P
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.